UTHR logo

UTHR EBITDA

Annual EBITDA:

$1.65B+$267.60M(+19.30%)
December 31, 2024

Summary

  • As of today, UTHR annual EBITDA is $1.65 billion, with the most recent change of +$267.60 million (+19.30%) on December 31, 2024.
  • During the last 3 years, UTHR annual EBITDA has risen by +$992.00 million (+149.76%).
  • UTHR annual EBITDA is now at all-time high.

Performance

UTHR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

Quarterly EBITDA:

$411.20M+$3.90M(+0.96%)
September 30, 2025

Summary

  • As of today, UTHR quarterly EBITDA is $411.20 million, with the most recent change of +$3.90 million (+0.96%) on September 30, 2025.
  • Over the past year, UTHR quarterly EBITDA has increased by +$49.00 million (+13.53%).
  • UTHR quarterly EBITDA is now at all-time high.

Performance

UTHR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

TTM EBITDA:

$1.60B+$49.00M(+3.16%)
September 30, 2025

Summary

  • As of today, UTHR TTM EBITDA is $1.60 billion, with the most recent change of +$49.00 million (+3.16%) on September 30, 2025.
  • Over the past year, UTHR TTM EBITDA has increased by +$252.60 million (+18.77%).
  • UTHR TTM EBITDA is now at all-time high.

Performance

UTHR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

UTHR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+19.3%+13.5%+18.8%
3Y3 Years+149.8%+25.7%+55.9%
5Y5 Years+2308.8%+76.6%+149.3%

UTHR EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+149.8%at high+117.8%at high+55.9%
5Y5-Yearat high+2308.8%at high+426.5%at high+194.7%
All-TimeAll-Timeat high+2127.9%at high+411.4%at high+1744.7%

UTHR EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$411.20M(+1.0%)
$1.60B(+3.2%)
Jun 2025
-
$407.30M(+1.2%)
$1.55B(+4.6%)
Mar 2025
-
$402.60M(+6.7%)
$1.48B(+2.2%)
Dec 2024
$1.65B(+19.3%)
$377.40M(+4.2%)
$1.45B(+7.7%)
Sep 2024
-
$362.20M(+7.0%)
$1.35B(+1.7%)
Jun 2024
-
$338.60M(-8.8%)
$1.32B(+0.9%)
Mar 2024
-
$371.30M(+35.6%)
$1.31B(+5.9%)
Dec 2023
$1.39B(+34.1%)
$273.80M(-19.5%)
$1.24B(+7.4%)
Sep 2023
-
$340.30M(+4.3%)
$1.15B(+1.1%)
Jun 2023
-
$326.30M(+9.6%)
$1.14B(+10.9%)
Mar 2023
-
$297.70M(+57.7%)
$1.03B(-0.3%)
Dec 2022
$1.03B(+56.1%)
$188.80M(-42.3%)
$1.03B(+0.5%)
Sep 2022
-
$327.20M(+52.5%)
$1.03B(+9.0%)
Jun 2022
-
$214.50M(-28.6%)
$940.70M(-2.1%)
Mar 2022
-
$300.50M(+63.8%)
$960.80M(+30.1%)
Dec 2021
$662.40M(-7.0%)
$183.40M(-24.3%)
$738.40M(+16.6%)
Sep 2021
-
$242.30M(+3.3%)
$633.40M(+1.5%)
Jun 2021
-
$234.60M(+200.4%)
$624.00M(+15.0%)
Mar 2021
-
$78.10M(-0.4%)
$542.50M(-15.7%)
Dec 2020
$712.30M(+1051.0%)
$78.40M(-66.3%)
$643.50M(+0.4%)
Sep 2020
-
$232.90M(+52.1%)
$641.10M(+6.1%)
Jun 2020
-
$153.10M(-14.5%)
$604.30M(-12.6%)
Mar 2020
-
$179.10M(+135.7%)
$691.80M(+3.7%)
Dec 2019
-$74.90M(-109.3%)
$76.00M(-61.2%)
$667.10M(-9.1%)
Sep 2019
-
$196.10M(-18.5%)
$733.50M(+5.0%)
Jun 2019
-
$240.60M(+55.8%)
$698.90M(+2.2%)
Mar 2019
-
$154.40M(+8.4%)
$683.80M(-19.0%)
Dec 2018
$808.70M(-0.1%)
$142.40M(-11.8%)
$844.20M(-0.5%)
Sep 2018
-
$161.50M(-28.4%)
$848.50M(-16.7%)
Jun 2018
-
$225.50M(-28.4%)
$1.02B(-7.3%)
Mar 2018
-
$314.80M(+114.6%)
$1.10B(+4.1%)
Dec 2017
$809.50M(-26.1%)
$146.70M(-55.7%)
$1.06B(-3.2%)
Sep 2017
-
$331.50M(+8.3%)
$1.09B(+8.4%)
Jun 2017
-
$306.20M(+12.8%)
$1.01B(+1.3%)
Mar 2017
-
$271.50M(+49.2%)
$993.40M(-9.1%)
Dec 2016
$1.10B(+1.3%)
$182.00M(-26.3%)
$1.09B(+1.8%)
Sep 2016
-
$246.80M(-15.8%)
$1.07B(-12.1%)
Jun 2016
-
$293.10M(-21.1%)
$1.22B(+10.2%)
Mar 2016
-
$371.40M(+127.8%)
$1.11B(+51.6%)
Dec 2015
$1.08B(+88.2%)
$163.02M(-58.8%)
$731.94M(-3.2%)
Sep 2015
-
$395.33M(+119.5%)
$756.43M(+124.5%)
Jun 2015
-
$180.09M(+2872.3%)
$336.97M(-1.1%)
Mar 2015
-
-$6.50M(-103.5%)
$340.84M(-40.3%)
Dec 2014
$575.00M(+75.2%)
$187.51M(+877.1%)
$571.04M(+57.4%)
Sep 2014
-
-$24.13M(-113.1%)
$362.80M(-27.3%)
Jun 2014
-
$183.96M(-17.8%)
$499.24M(+12.1%)
Mar 2014
-
$223.71M(+1178.7%)
$445.26M(+37.5%)
Dec 2013
$328.22M(-32.2%)
-$20.74M(-118.5%)
$323.76M(-32.6%)
Sep 2013
-
$112.31M(-13.6%)
$480.39M(+5.4%)
Jun 2013
-
$129.98M(+27.2%)
$455.71M(+2.5%)
Mar 2013
-
$102.20M(-24.8%)
$444.41M(-2.5%)
Dec 2012
$484.45M
$135.89M(+55.1%)
$455.59M(+17.4%)
Sep 2012
-
$87.63M(-26.2%)
$388.10M(-5.0%)
Jun 2012
-
$118.68M(+4.7%)
$408.44M(-0.2%)
DateAnnualQuarterlyTTM
Mar 2012
-
$113.39M(+65.8%)
$409.09M(+20.9%)
Dec 2011
$341.02M(+76.9%)
$68.41M(-36.6%)
$338.40M(+117.9%)
Sep 2011
-
$107.97M(-9.5%)
$155.33M(+35.7%)
Jun 2011
-
$119.33M(+179.5%)
$114.44M(+89.1%)
Mar 2011
-
$42.69M(+137.2%)
$60.52M(+10.8%)
Dec 2010
$192.78M(+348.0%)
-$114.66M(-270.9%)
$54.65M(-69.1%)
Sep 2010
-
$67.08M(+2.5%)
$176.90M(+42.6%)
Jun 2010
-
$65.41M(+77.7%)
$124.06M(+117.9%)
Mar 2010
-
$36.82M(+384.6%)
$56.94M(+34.1%)
Dec 2009
$43.04M(+163.5%)
$7.60M(-46.7%)
$42.45M(+143.7%)
Sep 2009
-
$14.24M(+929.0%)
-$97.19M(-5.4%)
Jun 2009
-
-$1.72M(-107.7%)
-$92.23M(-30.8%)
Mar 2009
-
$22.33M(+116.9%)
-$70.50M(+8.6%)
Dec 2008
-$67.75M(-405.4%)
-$132.05M(-787.6%)
-$77.10M(-255.6%)
Sep 2008
-
$19.20M(-4.1%)
$49.56M(+10.5%)
Jun 2008
-
$20.02M(+27.3%)
$44.84M(+33.2%)
Mar 2008
-
$15.73M(+392.0%)
$33.66M(+199.1%)
Dec 2007
$22.18M(-27.1%)
-$5.39M(-137.2%)
$11.25M(-46.3%)
Sep 2007
-
$14.48M(+63.8%)
$20.96M(+12.5%)
Jun 2007
-
$8.84M(+232.4%)
$18.64M(-15.1%)
Mar 2007
-
-$6.68M(-254.7%)
$21.96M(-34.9%)
Dec 2006
$30.45M(-32.8%)
$4.32M(-64.5%)
$33.72M(-16.5%)
Sep 2006
-
$12.16M(-0.1%)
$40.41M(-6.9%)
Jun 2006
-
$12.17M(+139.7%)
$43.41M(+0.9%)
Mar 2006
-
$5.08M(-53.9%)
$43.03M(-5.3%)
Dec 2005
$45.31M(+192.6%)
$11.01M(-27.4%)
$45.43M(+9.8%)
Sep 2005
-
$15.16M(+28.6%)
$41.38M(+27.2%)
Jun 2005
-
$11.79M(+57.8%)
$32.52M(+31.0%)
Mar 2005
-
$7.47M(+7.4%)
$24.83M(+59.2%)
Dec 2004
$15.48M(+268.3%)
$6.96M(+10.4%)
$15.59M(+170.4%)
Sep 2004
-
$6.30M(+53.7%)
$5.76M(+439.9%)
Jun 2004
-
$4.10M(+332.4%)
-$1.70M(+78.9%)
Mar 2004
-
-$1.76M(+38.5%)
-$8.04M(+12.2%)
Dec 2003
-$9.20M(+38.1%)
-$2.87M(-147.2%)
-$9.16M(-2.8%)
Sep 2003
-
-$1.16M(+48.4%)
-$8.92M(+35.2%)
Jun 2003
-
-$2.25M(+22.0%)
-$13.77M(-11.2%)
Mar 2003
-
-$2.88M(-9.9%)
-$12.38M(+22.5%)
Dec 2002
-$14.87M(+65.8%)
-$2.62M(+56.4%)
-$15.98M(+27.9%)
Sep 2002
-
-$6.01M(-593.4%)
-$22.16M(+18.9%)
Jun 2002
-
-$867.00K(+86.6%)
-$27.32M(+29.4%)
Mar 2002
-
-$6.48M(+26.4%)
-$38.70M(+12.3%)
Dec 2001
-$43.42M(+46.8%)
-$8.81M(+21.1%)
-$44.12M(+25.3%)
Sep 2001
-
-$11.16M(+8.9%)
-$59.06M(-1.7%)
Jun 2001
-
-$12.25M(-3.0%)
-$58.08M(+23.7%)
Mar 2001
-
-$11.89M(+49.9%)
-$76.12M(-3.6%)
Dec 2000
-$81.58M(-122.5%)
-$23.75M(-133.1%)
-$73.49M(-24.3%)
Sep 2000
-
-$10.19M(+66.4%)
-$59.11M(-5.5%)
Jun 2000
-
-$30.29M(-227.0%)
-$56.04M(-75.2%)
Mar 2000
-
-$9.26M(+1.1%)
-$31.99M(+8.9%)
Dec 1999
-$36.66M(-174.7%)
-$9.37M(-31.6%)
-$35.11M(-36.4%)
Sep 1999
-
-$7.12M(-14.1%)
-$25.74M(-38.2%)
Jun 1999
-
-$6.24M(+49.6%)
-$18.62M(-50.4%)
Mar 1999
-
-$12.38M
-$12.38M
Dec 1998
-$13.35M
-
-

FAQ

  • What is United Therapeutics Corporation annual EBITDA?
  • What is the all-time high annual EBITDA for United Therapeutics Corporation?
  • What is United Therapeutics Corporation annual EBITDA year-on-year change?
  • What is United Therapeutics Corporation quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for United Therapeutics Corporation?
  • What is United Therapeutics Corporation quarterly EBITDA year-on-year change?
  • What is United Therapeutics Corporation TTM EBITDA?
  • What is the all-time high TTM EBITDA for United Therapeutics Corporation?
  • What is United Therapeutics Corporation TTM EBITDA year-on-year change?

What is United Therapeutics Corporation annual EBITDA?

The current annual EBITDA of UTHR is $1.65B

What is the all-time high annual EBITDA for United Therapeutics Corporation?

United Therapeutics Corporation all-time high annual EBITDA is $1.65B

What is United Therapeutics Corporation annual EBITDA year-on-year change?

Over the past year, UTHR annual EBITDA has changed by +$267.60M (+19.30%)

What is United Therapeutics Corporation quarterly EBITDA?

The current quarterly EBITDA of UTHR is $411.20M

What is the all-time high quarterly EBITDA for United Therapeutics Corporation?

United Therapeutics Corporation all-time high quarterly EBITDA is $411.20M

What is United Therapeutics Corporation quarterly EBITDA year-on-year change?

Over the past year, UTHR quarterly EBITDA has changed by +$49.00M (+13.53%)

What is United Therapeutics Corporation TTM EBITDA?

The current TTM EBITDA of UTHR is $1.60B

What is the all-time high TTM EBITDA for United Therapeutics Corporation?

United Therapeutics Corporation all-time high TTM EBITDA is $1.60B

What is United Therapeutics Corporation TTM EBITDA year-on-year change?

Over the past year, UTHR TTM EBITDA has changed by +$252.60M (+18.77%)
On this page